Fly News Breaks for October 6, 2015
EXAS
Oct 6, 2015 | 09:40 EDT
Craig-Hallum recommends buying Exact Sciences on weakness related to the disappointing outcome from the USPSTF draft recommendation on colon cancer screening. Analyst Bill Bonello continues to believe Cologuard will be standard of care for colon cancer screening and said the Task Force recommendation will not impact Medicare coverage and Medicare alone is a $3.5B opportunity. Bonello rates shares a Buy and lowered his price target to $22 from $30.
News For EXAS From the Last 2 Days